BIM2b

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBIM2b
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionL-lactate dehydrogenase inhibitors
TargetsL-lactate dehydrogenase
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBeta Innov SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeta Innov SAS
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A